CLINN

What CLINN does

CLINN, founded in 2019 and headquartered in Milan, is a digital clinic specializing in medical cannabinoid therapy and operating as a brand of MAVA srl. The platform connects Italian patients seeking cannabis-based treatments with a network of 15+ affiliated prescribing physicians and 20+ authorized galenic pharmacies, delivered primarily through telemedicine with optional in-person visits at physician offices across 10+ Italian regions. CLINN reports cumulative management of 9,000+ patients and 20,000+ prescriptions generated, supported by near-perfect patient ratings (5/5 on miodottore.it from 187 reviews; 4.5/5 on Google).

The company's technology stack centers on ClinnCare, a digital follow-up and prescription-management platform that tracks four clinical indicators (quality of life, sleep quality, pain intensity, anxiety indices), coordinates prescriptions between doctors and pharmacies, and collects anonymized data for research. Surrounding products include the CLINN Card (a prescription-linked patient identification card for law-enforcement verification), Clinn Academy (an online training platform for physicians new to cannabinoid prescribing), a Welcome Kit with vaporizer and patient guide, a Legal Protection Service funded through two partner law firms, Fast Track (physician referral service), and the Essentialnio CBD/CBG wellness sub-brand across Ortho, Derma, Gyn, and Hair lines.

Revenue is generated through a mix of per-visit consultation fees (€150 first visit, €120 follow-up, €30 renewal), the CLINN Plus subscription pathway (€99 activation, €75 visits), administrative prescription-management fees, and product sales. Customer acquisition relies primarily on SEO-driven educational content covering 50+ condition pages, supplemented by partnerships with patient associations (CFU, ANPCI, A.pa.ca.m., CARLO THERAPY UPS), collaborations with four Italian universities, and physician referrals. The company operates with 1-10 employees and no disclosed external funding, suggesting a bootstrapped, founder-led capital structure.

Name

CLINN

Legal name

MAVA srl

Website

https://clinn.it

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

CLINN is an Italian digital clinic connecting patients with affiliated physicians and galenic pharmacies for cannabis-based therapeutic treatments, offering telemedicine consultations, prescription management, bundled legal protection, and physician training across Italy.

Ownership category

akta.pro rank

Product category

Medical Cannabis Services

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro industry

PRIMARYHLACANAH

Therapeutic Companion Apps (Drug-Device-Digital Combination)

Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

SECONDARYHLAKANAB

Sleep Medicine Clinic

Healthcare & Life Sciences/Specialist Medical Practice/Pulmonology & Sleep Medicine

Keywords

• Cannabinoid therapy services
• Medical cannabis platform
• Telemedicine consultations
• Digital health clinic
• Galenic pharmacy network

Headquarters

HQ city

Milan

HQ country

Italy

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

1. Medical Consultation Fees: CLINN charges for medical consultations and visits. The Standard pathway includes a first visit at €150, a follow-up visit at €120, and prescription renewals at €30 (or €20 for administrative management). The CLINN PLUS subscription pathway reduces per-visit costs to €75 each and prescription renewals to €20, while charging a €99 one-time activation fee.
2. CLINN PLUS Subscription: A subscription pathway offering reduced per-service costs, included CLINN Card and legal protection, and a 20% discount on products (vaporizers, bags, kits). The activation fee is €99 (one-time), with ongoing savings on consultations and renewals.
3. Prescription Management Services: Optional administrative fee for managing the prescription (€20 Standard / €15 PLUS). Also includes a €20 fee for the prescription redemption and home delivery service for patients who already have a prescription.
4. Product Sales (Welcome Kit and Accessories): Sale of the Welcome Kit (which includes CLINN Card, Vaporizzatore Oleo Panacea Inhaler, and Patient Guidebook), as well as individual accessories such as vaporizers and bags. PLUS members receive a 20% discount on these products.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

Core offering

CLINN is a digital clinic platform that connects patients seeking cannabinoid-based therapies with a nationwide network of affiliated prescribing physicians in Italy. The service includes telemedicine and in-person medical consultations, prescription management through the ClinnCare digital platform, coordination with authorized galenic pharmacies for medication dispensing, physician training via Clinn Academy, and a legal protection service for patients. Revenue is generated through consultation fees, a CLINN Plus subscription pathway, and product sales (Welcome Kit, vaporizers, CBD/CBG wellness line Essentialnio).

Product overview

CLINN is a digital platform and organizational infrastructure for therapeutic cannabinoid treatments in Italy. The core offering consists of the CLINN platform, the ClinnCare digital follow-up program, and the CLINN Network of affiliated physicians. The product portfolio includes patient-facing services (CLINN Card for identification and legal protection, Welcome Kit starter package, Essentialnio CBD/CBG wellness line), physician tools (Clinn Academy training platform), and support services (Fast Track referral service, Prescription Redemption, Legal Protection). CLINN Plus provides a subscription-based alternative to pay-per-visit pricing. The ecosystem connects patients with affiliated doctors and authorized galenic pharmacies through the ClinnCare platform for prescription management and treatment follow-up.

Differentiator

Problem solved

Functional benefit

Brands

• Clinn Academy: Training platform for medical professionals on cannabis therapeutics
• Clinn Care
• EssentialNio
• CLINN Plus
• Fast Track

Products and services

• ClinnCare A digital follow-up program platform that supports therapeutic journey management and simplifies interactions between patients, doctors, and pharmacies through a patient dashboard with health indicators, doctor prescription tools, pharmacy prescription management, and anonymous clinical data collection for research.
• CLINN Card A patient identification card that provides access to the entire CLINN service ecosystem, enables the legal protection service, and allows quick verification of therapy legitimacy during law enforcement checks through an alphanumeric code linking prescription to patient.
• Welcome Kit A comprehensive starter package for patients beginning medical cannabis treatment, containing the CLINN Card, an Oleo Panacea Inhaler vaporizer, and a Patient Handbook with therapy benefits guidance, drug storage instructions, travel documentation info, and law enforcement interaction guidelines.
• Legal Protection Service Free legal assistance service for medical cannabis patients in case of road traffic controls, helping them demonstrate treatment compliance and protect their rights. Covers legal expenses, expert opinions, and defense assistance, activated automatically with CLINN Card.
• Clinn Academy A training platform offering comprehensive educational programs for physicians on scientific, regulatory, and clinical aspects of cannabis therapeutics, including specialist courses on prescription, therapeutic plan setup, and structured follow-up management.
• CLINN Plus A subscription-based comprehensive care pathway offering reduced pricing on medical visits and services (€75 first visit, €75 follow-up, €20 renewal), including CLINN Card and Legal Protection bundled, plus 20% discounts on wellness products for ongoing therapeutic support. Activation fee is €99 one-time.
• Essentialnio A wellness product line developed using niosome biomedical technology containing CBD and CBG for daily use, available in four lines: Ortho (muscles and joints), Derma (sensitive skin), Gyn (intimate wellness), and Hair (hair vitality). Also available in professional versions for clinicians, physiotherapists, and wellness operators.
• Fast Track Service A priority referral service for general practitioners and healthcare operators to facilitate rapid patient access to specialist evaluation for cannabis therapy, offering free preliminary telemedicine assessment and remote symptom monitoring.
• Prescription Redemption Service Service for patients with existing medical cannabis prescriptions that simplifies pharmacy search, prescription pickup at home via certified courier, and drug delivery coordination with galenic pharmacies nationwide.
• CLINN Network A nationwide network of qualified healthcare professionals specializing in cannabinoid therapies, including doctors in regions like Liguria, Lazio, Sicily, Lombardy, Emilia Romagna, Umbria, Tuscany, Puglia, Friuli Venezia Giulia, and Campania, offering both in-person and telemedicine consultations.

Quantifiable outcome

• 65% of patients report at least a 2-point improvement on the NRS pain scale when treated with cannabis for chronic pain
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

14 partnerships are on record, tiered minor and core.

• Università degli studi di Milano-BicoccaminorStrategic or Co-development PartnerCLINN collaborates with the University of Milan-Bicocca for curricular and extracurricular internship programs, positioning the platform as an academic partner in medical cannabis education and research.
• Università degli studi di MilanominorStrategic or Co-development PartnerCLINN collaborates with the University of Milan for internship programs related to cannabis-based therapies, contributing to academic research and professional training.
• Università degli studi di TriesteminorStrategic or Co-development PartnerCLINN partners with the University of Trieste for internship programs, supporting the development of competencies in medical cannabis among future healthcare professionals.
• Università di CamerinominorStrategic or Co-development PartnerCLINN collaborates with the University of Camerino for training internships, integrating its platform into the academic curriculum of health science students.
• Studio Legale BullericoreImplementation/ SI/ Consulting PartnerStudio Legale Bulleri serves as CLINN's legal partner, providing free legal defense to qualifying patients who face roadside or other legal challenges related to their medical cannabis therapy. The firm is part of CLINN's funded legal protection program.
• Studio Legale ZainacoreImplementation/ SI/ Consulting PartnerStudio Legale Zaina is CLINN's second legal partner, offering free legal assistance to patients with valid cannabis prescriptions who face legal contestation. Together with Studio Legale Bulleri, they form the core of CLINN's legal protection offering.
• AvextraminorOthersAvextra is a cannabis-based medicine company that appears as a non-conditional supporter of CLINN. Their involvement signals industry alignment but specific collaboration details are not disclosed on the site.
• SomaìminorOthersSomaì is listed as a non-conditional supporter of CLINN alongside other cannabis industry companies, indicating alignment but without disclosed specific partnership terms.
• BedrocanminorOthersBedrocan, a major Dutch licensed cannabis producer, is listed as a non-conditional supporter of CLINN, suggesting industry recognition and alignment, though specific commercial terms are not detailed.
• TilrayminorOthersTilray, a global cannabis cultivation and production company, is listed as a non-conditional supporter of CLINN, providing brand credibility and industry association, with specific commercial terms undisclosed.
• CARLO THERAPY UPSminorGTM or Marketing PartnerCARLO THERAPY UPS is a patient association that offers its members preferential rates on CLINN services, acting as a referral channel and community advocate for medical cannabis therapy.
• CFU — Comitato Fibromialgici Uniti ItaliaminorGTM or Marketing PartnerCFU (Comitato Fibromialgici Uniti Italia), Italy's fibromyalgia patient committee, offers its members discounted access to CLINN's services, creating a mutually beneficial referral relationship between the platform and a highly relevant patient community.
• ANPCI — Associazione Nazionale Pazienti Cannabis ItaliaminorGTM or Marketing PartnerANPCI, the National Association of Cannabis Patients Italy, collaborates with CLINN to provide its members with preferred pricing on medical cannabis consultation services.
• A.pa.ca.m. — Associazione Pazienti Cannabis MedicaminorGTM or Marketing PartnerA.pa.ca.m. (Associazione Pazienti Cannabis Medica) is a patient association that offers its members preferential rates on CLINN services, functioning as a community-based referral partner.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Others

• Bedrocan: Dutch licensed medical cannabis producer listed as a CLINN supporter; a key upstream supplier for Italian pharmacies and adjacent ecosystem participant in CLINN's value chain.
• Tilray Brands: Global cannabis cultivator and product supplier listed as a CLINN supporter; represents the upstream supply ecosystem in which CLINN operates and a potential vertical integrator competitor.

Broad incumbents

• Kry (Livi): European digital primary-care telemedicine provider (Sweden, UK, France, Germany, Norway) representing the broad incumbent model of online physician consultations that CLINN's specialist cannabis service sits within.
• Doctolib: Europe's largest telemedicine and appointment-booking platform, present in Italy; serves as a broad incumbent whose generalist digital booking stack could compete with CLINN's specialist pathway.
• Push Doctor: UK-established digital GP / telemedicine incumbent offering online consultations, comparable as a same-format telemedicine platform that could expand into specialist verticals like CLINN's.

Direct peers

• Zerenia Clinics: Multi-country specialist medical cannabis clinic operator (UK, Colombia, Australia) offering in-person and telemedicine consultations, comparable to CLINN in clinical scope and patient model.
• Alternaleaf: UK medical cannabis clinic operating a digital-first patient pathway with specialist consultations and prescription fulfillment, closely mirroring CLINN's online-first model.
• The Medical Cannabis Clinics (Lyphe Group): UK chain of specialist medical cannabis clinics with telemedicine pathways, serving similar patient profiles (chronic pain, neurological, mental health) with prescription-based cannabinoid therapy.
• Kanabo Group: UK-listed medical cannabis telemedicine and clinic platform offering online consultations and prescription delivery, directly comparable to CLINN's digital clinic model for cannabinoid therapy.
• Mamedica: UK-based specialist medical cannabis clinic providing online consultations and prescriptions for chronic conditions, paralleling CLINN's specialist digital clinic offering.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/ClinnHealth
• LinkedInlinkedin.com/company/clinn-network

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CLINN